Ebitda Zmiana Data
AbbVie USD 6.75B 433M 2023-09
Abbott USD 2.41B 132M 2023-12
ALKERMES USD 68.51M 189.7M 2023-09
Amgen USD 3.66B 713M 2023-12
AstraZeneca USD 3.43B 412M 2023-09
Biogen USD 652.1M 241.8M 2023-12
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Bristol-Myers Squibb USD 4.89B 261M 2023-12
Eisai JPY 15.17B 20.62B 2023-09
Eli Lilly USD 3.84B 1.88B 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
GlaxoSmithKline GBP 3.17B 729M 2023-09
Infinity Pharmaceuticals USD -10014000 1.39M 2023-06
J&J USD 6.46B 1.51B 2023-12
Merck USD 7.51B 11.02B 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pacira USD 52.49M 12.98M 2023-12
Perrigo USD 168.6M 11.2M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Revance Therapeutics USD -41961000 20.01M 2023-09
Roche Holding CHF 12.35B 1.92B 2023-06
UCB EUR 656M 205M 2023-06
Ultragenyx Pharmaceutical USD -137906000 4.69M 2023-09
United Therapeutics USD 277.4M 62.9M 2023-12
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09
Zoetis USD 859M 60M 2023-12



AbbVie - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.